Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
HAMPTON, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the fourth quarter and year ended December 31,...
-
Relypsa reports encouraging initial demand for VeltassaVeltassa added to CMS 2016 Formulary Reference File and agreements signed with Express Scripts and CVS Caremark, the two largest pharmacy...
-
Valneva Posts 96% Revenue Growth in 2015; Forecasts 2016 Revenues of €90 to €100 Million The Company today announced its unaudited FY 2015 revenues, unaudited year-end cash...
-
Valneva Posts 96% Revenue Growth in 2015; Forecasts 2016 Revenues of €90 to €100 Million The Company today announced its unaudited FY 2015 revenues, unaudited year-end cash balance and 2016...
-
Valneva : chiffre d'affaires en hausse de 96% en 2015; Chiffre d'affaires 2016 attendu entre €90 et €100 millions Le Groupe a publié ce jour son chiffre d'affaires et sa trésorerie (non-audités)...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Bagsværd, den 23. februar 2016 - Novo Nordisk...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Bagsværd, Denmark, 23 February 2016 - Novo...
-
Deerfield Beach, FL, Feb. 23, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Hyaluronic Acid (Single Injection, Three Injection, Five Injection) Market for...
-
FDA’s acceptance includes Sanofi’s redemption of a Priority Review Voucher with the NDA filing Based on a six months priority review process, a US regulatory decision is expected in August...
-
FDA’s accept omfatter den prioritetskupon, Sanofi har indløst som en del af registreringsansøgningen Med udgangspunkt i den forkortede behandlingstid på seks måneder forventes en...